Neutralizing antibody responses to three XBB protein vaccines in older adults
Abstract The ongoing COVID-19 pandemic has underscored the importance of strong immune defenses against emerging SARS-CoV-2 variants. While COVID-19 vaccines containing XBB subvariants have proven effective in neutralizing new SARS-CoV-2 variants, a gap remains in knowledge regarding neutralizing an...
Saved in:
Main Authors: | Guo-Jian Yang, Mei Lu, Rui-Rui Chen, Shuang-Qing Wang, Sheng Wan, Xue-Dong Song, Guo-Ping Cao, Lei Lv, Xue-Juan He, Bing-Dong Zhan, Mai-Juan Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-025-02132-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters
by: Ryuta Uraki, et al.
Published: (2025-02-01) -
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages
by: Jingyun Yang, et al.
Published: (2025-01-01) -
A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
by: Ping Li, et al.
Published: (2025-01-01) -
Factors associated with the formation of neutralizing antibodies post-vaccination: a lesson from COVID-19 vaccination
by: Hana Ratnawati, et al.
Published: (2025-01-01) -
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
by: Zhifei Chen, et al.
Published: (2025-01-01)